- Home
- FPH vs CELC Comparison
FPH vs CELC Comparison
Compare FPH & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPH
- CELC
- Stock Information
- Founded
- FPH 2009
- CELC 2011
- Country
- FPH United States
- CELC United States
- Employees
- FPH N/A
- CELC N/A
- Industry
- FPH Real Estate
- CELC Medical Specialities
- Sector
- FPH Finance
- CELC Health Care
- Exchange
- FPH Nasdaq
- CELC Nasdaq
- Market Cap
- FPH 338.2M
- CELC 327.3M
- IPO Year
- FPH 2017
- CELC 2017
- Fundamental
- Price
- FPH $4.95
- CELC $10.24
- Analyst Decision
- FPH
- CELC Strong Buy
- Analyst Count
- FPH 0
- CELC 6
- Target Price
- FPH N/A
- CELC $30.17
- AVG Volume (30 Days)
- FPH 155.4K
- CELC 392.7K
- Earning Date
- FPH 04-24-2025
- CELC 05-14-2025
- Dividend Yield
- FPH N/A
- CELC N/A
- EPS Growth
- FPH 25.45
- CELC N/A
- EPS
- FPH 0.96
- CELC N/A
- Revenue
- FPH $237,926,000.00
- CELC N/A
- Revenue This Year
- FPH N/A
- CELC N/A
- Revenue Next Year
- FPH N/A
- CELC N/A
- P/E Ratio
- FPH $5.16
- CELC N/A
- Revenue Growth
- FPH 12.37
- CELC N/A
- 52 Week Low
- FPH $2.83
- CELC $7.58
- 52 Week High
- FPH $6.71
- CELC $19.77
- Technical
- Relative Strength Index (RSI)
- FPH 44.93
- CELC 54.38
- Support Level
- FPH $4.61
- CELC $7.58
- Resistance Level
- FPH $5.15
- CELC $10.48
- Average True Range (ATR)
- FPH 0.27
- CELC 1.04
- MACD
- FPH -0.01
- CELC 0.17
- Stochastic Oscillator
- FPH 41.16
- CELC 80.01
About FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.